Calendar
event
Ex dividend date
12 May 2025
event_available
Last Dividend Payment
01 Jan 1970
About Drägerwerk AG & Co. KGaA
Ticker
info
DRW8
Trading on
info
XETRA
ISIN
info
DE0005550602
Industry
info
Medical Devices
Sector
info
Healthcare
CEO
info
-
Headquarters
info
Moislinger Allee 53-55, Lübeck, undefined, Germany, 23558
Employees
info
16,684
Website
info
draeger.com
Drägerwerk AG & Co. KGaA operates as a medical and safety technology company worldwide. It develops, produces, and markets system solutions, devices, and services for the medical division, including emergency medicine, perioperative care, intensive care, and perinatal medicine. The company also develops, produces, and markets products, system solutions, and services for personal protection, gas measurement technology, and comprehensive risk management to customers in industry and mining sectors, as well as public sectors, such as fire departments, police, and disaster protection. Its products include patient monitoring systems; anaesthesia machines; medical ventilators and lung monitoring; neonatal incubators and thermoregulation; phototherapy lights and bilirubinometers; surgical and examination lights; medical pendants and infrastructure design; medical gas pipeline system in hospitals; and hospital consumables and accessories, as well as hospital planning and design services. In addition, the company offers alcohol and drug testing; fixed gas detectors; hazmat suits; portable gas detection; head protection; rescue and escape; respiratory protection; safety-training systems; thermal imaging cameras; and workshop solution and breathing gas supply. Further, it provides various training and services. The company was founded in 1889 and is headquartered in Lübeck, Germany. Drägerwerk AG & Co. KGaA operates as a subsidiary of Stefan DrÄGer Gmbh.
Metrics
BasicAdvanced
Market cap
info
€1.24B
P/E ratio
info
9.5
EPS
info
€6.42
Dividend Yield
info
3.37%
Beta
info
0.54
Forward P/E ratio
info
0
EBIDTA
info
€243M
Ex dividend date
info
2025-05-12
Price & volume
Market cap
info
€1.24B
Average daily volume
info
0M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
€2.03
Dividend yield
info
3.37%
Forward dividend per share
info
€1.97
Forward dividend yield
info
3.27%
Payout ratio
info
30.02%
Valuation
P/E ratio
info
9.5
Forward P/E
info
0
PEG ratio
info
0
Trailing P/E
info
9.5
Price to sales
info
0.36
Price to book
info
0.77
Earnings
EPS
info
€6.42
EPS estimate (current quarter)
info
€0.00
EPS estimate (next quarter)
info
€0.00
EBITDA
info
€243M
Revenues (TTM)
info
€3.42B
Revenues per share (TTM)
info
€179.75
Technicals
Beta
info
0.54
52-week High
info
€64.80
52-week Low
info
€37.51
50-day moving average
info
€57.77
200-day moving average
info
€54.53
Short ratio
info
0
Short %
info
0.00%
Management effectiveness
ROE (TTM)
info
8.20%
ROA (TTM)
info
3.33%
Profit margin
info
3.54%
Gross profit margin
info
€1.55B
Operating margin
info
6.88%
Growth
Quarterly earnings growth (YoY)
info
-57.70%
Quarterly revenue growth (YoY)
info
7.60%
Share stats
Outstanding Shares
info
10.2M
Float
info
10.6M
Insiders %
info
71.62%
Institutions %
info
10.23%
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
€0.78
-
-
Q3 • 24Beat
€4.05
-
-
Q1 • 25Beat
€0.60
-
-
Q2 • 25Beat
€1.91
-
-
Q3 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
€780M
€11.3M
1.44%
Q2 • 25
€833M
€35.7M
4.28%
Q3 • 25
6.83%
216.85%
196.59%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
€2.99B
€1.52B
50.91%
Q2 • 25
€3.03B
€1.52B
50.26%
Q3 • 25
1.48%
0.20%
-1.27%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
€-38.1M
€-35.9M
€6.3M
€-54.5M
Q2 • 25
€92.6M
-
€-52.3M
-
Q3 • 25
-343.33%
-
-926.83%
NaN%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Drägerwerk AG & Co. KGaA share?
Collapse

Drägerwerk AG & Co. KGaA shares are currently traded for undefined per share.

How many shares does Drägerwerk AG & Co. KGaA have?
Collapse

Drägerwerk AG & Co. KGaA currently has 10.2M shares.

Does Drägerwerk AG & Co. KGaA pay dividends?
Collapse

Yes, Drägerwerk AG & Co. KGaA does pay dividends.

What is Drägerwerk AG & Co. KGaA 52 week high?
Collapse

Drägerwerk AG & Co. KGaA 52 week high is €64.80.

What is Drägerwerk AG & Co. KGaA 52 week low?
Collapse

Drägerwerk AG & Co. KGaA 52 week low is €37.51.

What is the 200-day moving average of Drägerwerk AG & Co. KGaA?
Collapse

Drägerwerk AG & Co. KGaA 200-day moving average is €54.53.

Who is Drägerwerk AG & Co. KGaA CEO?
Collapse

The CEO of Drägerwerk AG & Co. KGaA is -.

How many employees Drägerwerk AG & Co. KGaA has?
Collapse

Drägerwerk AG & Co. KGaA has 16,684 employees.

What is the market cap of Drägerwerk AG & Co. KGaA?
Collapse

The market cap of Drägerwerk AG & Co. KGaA is €1.24B.

What is the P/E of Drägerwerk AG & Co. KGaA?
Collapse

The current P/E of Drägerwerk AG & Co. KGaA is 9.5.

What is the EPS of Drägerwerk AG & Co. KGaA?
Collapse

The EPS of Drägerwerk AG & Co. KGaA is €6.42.

What is the PEG Ratio of Drägerwerk AG & Co. KGaA?
Collapse

The PEG Ratio of Drägerwerk AG & Co. KGaA is 0.